Case Study
Disease area strategy: patient expectations for 2030
- Conditions: Respiratory • Dermatology
- Countries: Global Scope
- Timeline: 2 to 3 months
Key Deliverables
Client
A pharma company exploring new disease areas for early assets
Key Question
How might we shape our disease area strategy and early assets to meet patient expectations in 2030?
Our approach
In collaboration with the client’s insight partner, we extracted insights from primary qualitative research with medical experts and patient associations, to select, evidence and present the key trends shaping patient expectations in 2030.
We ran an innovation scan to showcase ‘early signals’ of these trends and help our client understand potential implications for their assets’ development strategy (e.g. diversity in clinical trials, novel endpoints, digital companions…)
Results
We helped our client to identify patient-friendly exploratory endpoints, as well as digital solutions that may impact future patient journey
